-
Gauff finds a way into the Cincinnati fourth round
-
NASA images reveal crater left by SpaceX rocket's Moon crash
-
ZZ Top drummer Frank Beard dies at age 77
-
UN atomic watchdog says found tons of nuclear material at Syria site
-
Bayern's Musiala reveals 'neurological disorder' after on-field collapse
-
Ecuadoran diplomat enters race to be next UN chief
-
Angelique Kidjo immortalised on Hollywood Walk of Fame
-
US sanctions ICC chief Tomoko Akane of Japan
-
France to expel two Iranian diplomats: foreign minister
-
US moves to open vast tracts of pristine forests to logging
-
Spain's Granada closes iconic Alhambra as new quake hits
-
US sanctions International Criminal Court chief Tomoko Akane of Japan
-
Venus, Stephens, Monfils named among US Open wild cards
-
Meta hooked children and misled public: prosecutors
-
Rodri joins La Liga champions Barcelona from Manchester City
-
France's first women's rights minister Yvette Roudy dies, aged 97
-
Disney, ABC sue US regulator over threat to broadcast licenses
-
French producer Nicolas Altmayer, Dior PR chief Favier die in car crash
-
Trump, Carney hold talks as new US tariffs on Canada loom
-
Bezos consortium bought nearly 40 percent of Liverpool: report
-
Germany opens new drone research centre as security threats mount
-
Trump says no Iran talks planned, claims Hormuz 'new US territory'
-
How only a few tree species drive Amazon forest recovery
-
Canada seeks to avert new US tariffs as deadline looms
-
Ivonne A-Baki enters race to be next UN chief
-
US primaries test Democrat comeback hopes in Trump stronghold
-
Ukraine says Russian strike kills 10 in northeast region
-
Scientists discover how narwhals grow nature's only straight tusk
-
Meta in court over child social media addiction
-
DR Congo Ebola outbreak 'far from being under control': WHO chief
-
Vieira appointed Senegal head coach after World Cup disappointment
-
Firefighters in 'decisive' push to encircle Belgian wildfire
-
F1's Albon re-signs with Williams for 2027
-
Tribal Partners with ServiceNow to Empower Enterprise Teams to Build and Deploy Apps & Agents
-
Borderless.xyz Deepens Africa Coverage as CrissCross Goes Live on Its Network
-
Fusion Markets Extends Negative Balance Protection to Clients Globally
-
Pakistan court orders ex-PM Khan moved from jail to hospital
-
India close on victory in first Test against Sri Lanka
-
'Lonely place': Black UK academics slam racism after Arday's death
-
Three lightly injured as new quake hits Spain's Granada
-
UK PM says not embarrassed by hoax messages with fake Trump aide
-
Syria, US say Israel struck military air base in Idlib province
-
West Bank siege exposes Israel army inaction on settler violence
-
France probes Russian disinfo campaign against centrist candidates
-
Four-time champion Roglic to ride Vuelta after training crash
-
Stocks mostly drop as Mideast hopes dim, interest rates rise
-
Ukrainian convicted in Germany over Russian sabotage plot
-
Bayern's Musiala returns to training after on-field collapse
-
Beleaguered FIFA chief Infantino rids himself of critic Lamour
-
China's Baidu, betting on AI, posts fifth straight quarterly revenue drop
US appeals court temporarily halts mail delivery of abortion pill
A US appeals court on Friday temporarily halted mail delivery of mifepristone, the medication used in the majority of abortions in the United States.
A three-judge panel of the 5th Circuit Court of Appeals delivered the order in a lawsuit brought by the southern state of Louisiana, which has some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA).
The order by the conservative-dominated court requires women seeking abortions anywhere in the United States to obtain mifepristone in person from health clinics, and bans delivery by mail or through a pharmacy.
The appeals court overturned a lower court ruling that allowed mifepristone to continue to be delivered by mail while the FDA conducts a review of its regulations regarding the drug.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and was published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The FDA originally approved mifepristone in 2000. It is the most common method for abortion care in the United States and is also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
Louisiana Attorney General Liz Murrill welcomed the appeals court decision calling it a "Victory for Life!"
"The Biden abortion cartel facilitated the deaths of thousands of Louisiana babies (and millions in other states) through illegal mail-order abortion pills," Murrill said. "Today, that nightmare is over."
- 'Isn't about science' -
Nancy Northup, president and CEO of the Center for Reproductive Rights, condemned the appeals court ruling, which is expected to be appealed to the US Supreme Court.
"This isn't about science -- it's about making abortion as difficult, expensive, and unreachable as possible," Northup said in a statement.
Julia Kaye, an attorney with the American Civil Liberties Union (ACLU), said "anti-abortion politicians have just made it much harder for people everywhere in the country to get a medication that abortion and miscarriage patients have been safely using for more than 25 years."
Some 20 states have banned or restricted abortion since the Supreme Court in June 2022 overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century.
Polls show a majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure or ban it outright.
In 2024, the US Supreme Court rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.
T.Ward--AMWN